Life Sciences BG | The individual-cell-based cryo-chip for the cryopreservation, manipulation and observation of spatially identifiable cells. II: Functional activity of cryopreserved cells

English

The individual-cell-based cryo-chip for the cryopreservation, manipulation and observation of spatially identifiable cells. II: Functional activity of cryopreserved cells

Background:
The cryopreservation and thawing processes are known to induce many deleterious effects in cells and might be detrimental to several cell types. There is an inherent variability in cellular responses among cell types and within individual cells of a given population with regard to their ability to endure the freezing and thawing process. The aim of this study was to evaluate the fate of cryo-preserved cells within an optical cryo apparatus: the individual-cell-based cryo-chip (i3C) by monitoring several basic cellular functional activities at the resolution of individual cells.
Results:
In the present study, U937 cells underwent the freezing and thawing cycle in the i3C device. Then a panel of vital tests was performed, including the number of dead cells (PI staining), apoptotic rate (Annexin V staining), mitochondrial membrane potential (TMRM staining), cytoplasm membrane integrity and intracellular metabolism (FDA staining), as well as post-thawing cell proliferation assay. Cells that underwent the freezing - thawing cycle in i3C devices exhibited the same functional activity as control cells. Moreover, the combination of the multiparametric analysis at a single cell resolution and the optical and biological features of the device enable an accurate determination of the functional status of individual cells and subsequent retrieval and utilization of the most valuable cells.
Conclusions:
The means and methodologies described here enable the freezing and thawing of spatially identifiable cells, as well as the efficient detection of viable, specific, highly biologically active cells for future applications.

Read the original article at BMC Cell Biology.

Published: Nov 2010, Updated: 7th Nov

Most recent items in "Молекулярна и клетъчна биология":

7th Nov Молекулярна и клетъчна биология: Identification of binding partners interacting with the {alpha}1-N-propeptide of type V collagen

The predominant form of type V collagen is the [α1(V)]2α2(V) heterotrimer. Mutations in COL5A1 or COL5A2, encoding respectively the α1(V)- and α2(V)-collagen chain, cause classic Ehlers-Danlos syndrome (EDS), a heritable connective tissue disorder, characterized by fragile hyperextensible skin a...

7th Nov Молекулярна и клетъчна биология: Mcm10 proteolysis initiates before the onset of M-phase

Background:
Mcm10 protein is essential for initiation and elongation phases of replication. Human cells proteolyze Mcm10 during mitosis, presumably to ensure a single round of replication. It has been proposed that anaphase promoting complex ubiquitinates Mcm10 in late M and early G...

7th Nov Молекулярна и клетъчна биология: Human ASPM participates in spindle organisation, spindle orientation and cytokinesis

Background:
Mutations in the Abnormal Spindle Microcephaly related gene (ASPM) are the commonest cause of autosomal recessive primary microcephaly (MCPH) a disorder characterised by a small brain and associated mental retardation. ASPM encodes a mitotic spindle pole associated protein. It is su...

7th Nov Молекулярна и клетъчна биология: Specific amino acids in the BAR domain allow homodimerization and prevent heterodimerization of sorting nexin 33

Sorting nexin 33 (SNX33) is a homolog of the endocytic protein SNX9 and has been implicated in actin polymerization and the endocytosis of the amyloid precursor protein. SNX33 belongs to the large family of BAR domain-containing proteins, which alter cellular protein trafficking by modulating cellul...

19th Oct Молекулярна и клетъчна биология: CTD small phosphatase like 2 (CTDSPL2) can increase epsilon- and gamma-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood

Background:
A potential strategy for treatment of sickle cell disease (SCD) and beta-thalassemia in adults is reactivation of the epsilon- and gamma-globin genes in the adult. We aimed to identify trans-activators of epsilon- and gamma-globin expression and provide new candidate targets for eff...